Efficacy and Safety of Topic Ketorolac to Treat Center Point Thickness Secondary to Panphotocoagulation in Proliferative Diabetic Retinopathy
Sponsor study identifier
interventional
44
1 country
1
Study Start
June 2009
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
March 2015
Actual (reported)Study Completion
March 2015
Actual (reported)The purpose of this study is to determine the efficacy and safety of topic ketorolac in treatment for center point thickness secondary to panphotocoagulation in proliferative diabetic retinopathy.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
March 2015
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
May 19, 2009
Actual (reported)May 22, 2009
Actual (reported)June 2009
Date type not reportedThis date has not been verified as actual or estimated.
March 2015
Actual (reported)March 2015
Actual (reported)center subfield mean thickness using Stratus OCT measured in microns
baseline, 24, 48 and 168 hours after treatment
center point thickness using Stratus OCT, measured in microns
baseline, 24, 48 and 168 hours after treatment
macular volume using Stratus OCT, measured in cubic millimeters
baseline, 24, 48 and 168 hours after treatment
ocular topic ketorolac used 4 times a day during a week after panphotocoagulation
ocular lubricant drops 4 times a day during one week after panphotocoagulation
Presentation 5 mg/ml; Dosage: one drop (0.25 mg) four times a day during one week after panphotocoagulation
Presentation: alcohol polivinilico 14 mg/ml; Dosage: one drop (0.7 mg alcohol polivinilico) four times a day during one week after panphotocoagulation
Virgilio Lima Gomez
Mexico City, Mexico City, 07760, Mexico
Virgilio Lima Gomez, MD, MSc
Hospital Juarez de Mexico
Dulce M Razo Blanco Hernandez, MD
Hospital Juarez de Mexico
Juan Asbun Bojalil, MD, PhD
Hospital Juarez de Mexico
44 participants (actual enrollment reported by the registry).
First Submitted
May 19, 2009
First Posted
May 22, 2009
Study Start
June 2009
Date type not reportedThis date has not been verified as actual or estimated.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Primary Completion
March 2015
Actual (reported)Study Completion
March 2015
Actual (reported)Last Updated
March 20, 2015
Record last verified: 2015-03
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: